Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Comparative Hepatology
Published in: Comparative Hepatology 1/2004

Open Access 01-01-2004 | Research

Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocytes from griseofulvin-intoxicated mice

Authors: Michel Fausther, Louis Villeneuve, Monique Cadrin

Published in: Comparative Hepatology | Issue 1/2004

Login to get access

Abstract

Background

Keratins are members of the intermediate filaments (IFs) proteins, which constitute one of the three major cytoskeletal protein families. In hepatocytes, keratin 8 and 18 (K8/18) are believed to play a protective role against mechanical and toxic stress. Post-translational modifications such as phosphorylation and glycosylation are thought to modulate K8/18 functions. Treatment of mouse with a diet containing griseofulvin (GF) induces, in hepatocytes, modifications in organization, expression and phosphorylation of K8/18 IFs and leads, on the long term, to the formation of K8/18 containing aggregates morphologically and biochemically identical to Mallory bodies present in a number of human liver diseases. The aim of the present study was to investigate the relationship between the level and localization of the stress inducible heat shock protein 70 kDa (HSP70i) and the level and localization of K8/18 phosphorylation in the liver of GF-intoxicated mice. The role of these processes in Mallory body formation was studied, too. The experiment was carried out parallely on two different mouse strains, C3H and FVB/n.

Results

GF-treatment induced an increase in HSP70i expression and K8 phosphorylation on serines 79 (K8 S79), 436 (K8 S436), and K18 phosphorylation on serine 33 (K18 S33) as determined by Western blotting. Using immunofluorescence staining, we showed that after treatment, HSP70i was present in all hepatocytes. However, phosphorylated K8 S79 (K8 pS79) and K8 S436 (K8 pS436) were observed only in groups of hepatocytes or in isolated hepatocytes. K18 pS33 was increased in all hepatocytes. HSP70i colocalized with MBs containing phosphorylated K8/18. Phophorylation of K8 S79 was observed in C3H mice MBs but was not present in FVB/n MBs.

Conclusions

Our results indicate that GF intoxication represents a stress condition affecting all hepatocytes, whereas induction of K8/18 phosphorylation is not occurring in every hepatocyte. We conclude that, in vivo, there is no direct relationship between GF-induced stress and K8/18 phosphorylation on the studied sites. The K8/18 phosphorylation pattern indicates that different cell signaling pathways are activated in subpopulations of hepatocytes. Moreover, our results demonstrate that, in distinct genetic backgrounds, the induction of K8/18 phosphorylation can be different.
Appendix
Available only for authorised users
Literature
1.
Lazarides E: Intermediate filaments as mechanical integrators of cellular space. Nature. 1980, 283: 249-256.CrossRefPubMed
2.
Fuchs E, Weber K: Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 1994, 63: 345-382.CrossRefPubMed
3.
Schliwa M: The cytoskeleton: An introductory survey. In : Alfert M, Beerman W, Goldstein L, Porter K R, eds Cell Biology Monograhs. Edited by: Springer-Verlag. 1986, New York, Wien, 13:
4.
Herrmann H, Hesse M, Reichenzeller M, Aebi U, Magin TM: Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int Rev Cytol. 2003, 223: 83-175.CrossRefPubMed
5.
Steinert PM, Roop DR: Molecular and cellular biology of intermediate filaments. Annu Rev Biochem. 1988, 57: 593-625. 10.1146/annurev.bi.57.070188.003113.CrossRefPubMed
6.
Moll R, Franke WW, Schiller DL, Geiger B, Krepler R: The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982, 31: 11-24. 10.1016/0092-8674(82)90400-7.CrossRefPubMed
7.
Vassar R, Coulombe PA, Degenstein L, Albers K, Fuchs E: Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 1991, 64: 365-380. 10.1016/0092-8674(91)90645-F.CrossRefPubMed
8.
Fuchs E, Cleveland DW: A structural scaffolding of intermediate filaments in health and disease. Science. 1998, 279: 514-519. 10.1126/science.279.5350.514.CrossRefPubMed
9.
Coulombe PA, Omary MB: 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol. 2002, 14: 110-122. 10.1016/S0955-0674(01)00301-5.CrossRefPubMed
10.
Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E: Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 1991, 66: 1301-1311. 10.1016/0092-8674(91)90051-Y.CrossRefPubMed
11.
Porter RM, Lane EB: Phenotypes, genotypes and their contribution to understanding keratin function. Trends Genet. 2003, 19: 278-285. 10.1016/S0168-9525(03)00071-4.CrossRefPubMed
12.
Loranger A, Duclos S, Grenier A, Price J, Wilson-Heiner M, Baribault H, Marceau N: Simple epithelium keratins are required for maintenance of hepatocyte integrity. Am J Pathol. 1997, 151: 1673-1683.PubMedCentralPubMed
13.
Ku NO, Michie S, Oshima RG, Omary MB: Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol. 1995, 131: 1303-1314. 10.1083/jcb.131.5.1303.CrossRefPubMed
14.
Ku NO, Darling JM, Krams SM, Esquivel CO, Keeffe EB, Sibley RK, Lee YM, Wright TL, Omary MB: Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies. Proc Natl Acad Sci U S A. 2003, 100: 6063-6068. 10.1073/pnas.0936165100.PubMedCentralCrossRefPubMed
15.
Ku NO, Gish R, Wright TL, Omary MB: Keratin 8 mutations in patients with cryptogenic liver disease. N Engl J Med. 2001, 344: 1580-1587. 10.1056/NEJM200105243442103.CrossRefPubMed
16.
Ku NO, Wright TL, Terrault NA, Gish R, Omary MB: Mutation of human keratin 18 in association with cryptogenic cirrhosis. J Clin Invest. 1997, 99: 19-23.PubMedCentralCrossRefPubMed
17.
Denk H, Krepler R, Lackinger E, Artlieb U, Franke WW: Immunological and biochemical characterization of the keratin-related component of Mallory bodies: a pathological pattern of hepatocytic cytokeratins. Liver. 1982, 2: 165-175.CrossRefPubMed
18.
Hazan R, Denk H, Franke WW, Lackinger E, Schiller DL: Change of cytokeratin organization during development of Mallory bodies as revealed by a monoclonal antibody. Lab Invest. 1986, 54: 543-553.PubMed
19.
Jensen K, Gluud C: The Mallory body: theories on development and pathological significance (Part 2 of a literature survey). Hepatology. 1994, 20: 1330-1342. 10.1016/0270-9139(94)90776-5.CrossRefPubMed
20.
Jensen K, Gluud C: The Mallory body: morphological, clinical and experimental studies (Part 1 of a literature survey). Hepatology. 1994, 20: 1061-1077. 10.1016/0270-9139(94)90776-5.CrossRefPubMed
21.
Denk H, Stumptner C, Zatloukal K: Mallory bodies revisited. J Hepatol. 2000, 32: 689-702. 10.1016/S0168-8278(00)80233-0.CrossRefPubMed
22.
Mayer R, Lowe J, Landon M, McDermott H, Tuckwell J, Doherty F, Laszlo L: Ubiquitin and the lysosome system: molecular pathological and experimental findings. Eds Maresca, B and Lindquist, S. Edited by: Springer-Verlag. 1991, New York, Heidelberg, pp. 299-314.
23.
Yuan QX, Marceau N, French BA, Fu P, French SW: Heat shock in vivo induces Mallory body formation in drug primed mouse liver. Exp Mol Pathol. 1995, 63: 63-76. 10.1006/exmp.1995.1031.CrossRefPubMed
24.
Riley NE, Li J, McPhaul LW, Bardag-Gorce F, Lue YH, French SW: Heat shock proteins are present in mallory bodies (cytokeratin aggresomes) in human liver biopsy specimens. Exp Mol Pathol. 2003, 74: 168-172. 10.1016/S0014-4800(02)00020-5.CrossRefPubMed
25.
Liao J, Ku NO, Omary MB: Stress, apoptosis, and mitosis induce phosphorylation of human keratin 8 at Ser-73 in tissues and cultured cells. J Biol Chem. 1997, 272: 17565-17573. 10.1074/jbc.272.28.17565.CrossRefPubMed
26.
Omary MB, Ku NO, Liao J, Price D: Keratin modifications and solubility properties in epithelial cells and in vitro. Subcell Biochem. 1998, 31: 105-140.PubMed
27.
Toivola DM, Zhou Q, English LS, Omary MB: Type II keratins are phosphorylated on a unique motif during stress and mitosis in tissues and cultured cells. Mol Biol Cell. 2002, 13: 1857-1870. 10.1091/mbc.01-12-0591.PubMedCentralCrossRefPubMed
28.
Denk H, Gschnait F, Wolff K: Hepatocellar hyalin (Mallory bodies) in long term griseofulvin-treated mice: a new experimental model for the study of hyalin formation. Lab Invest. 1975, 32: 773-776.PubMed
29.
Ku NO, Zhou X, Toivola DM, Omary MB: The cytoskeleton of digestive epithelia in health and disease. Am J Physiol. 1999, 277: G1108-37.PubMed
30.
Baribault H, Penner J, Iozzo RV, Wilson-Heiner M: Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev. 1994, 8: 2964-2973.CrossRefPubMed
31.
Baribault H, Price J, Miyai K, Oshima RG: Mid-gestational lethality in mice lacking keratin 8. Genes Dev. 1993, 7: 1191-1202.CrossRefPubMed
32.
Gilbert S, Loranger A, Daigle N, Marceau N: Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J Cell Biol. 2001, 154: 763-773. 10.1083/jcb.200102130.PubMedCentralCrossRefPubMed
33.
Cadrin M, Hovington H, Marceau N, McFarlane-Anderson N: Early perturbations in keratin and actin gene expression and fibrillar organisation in griseofulvin-fed mouse liver. J Hepatol. 2000, 33: 199-207. 10.1016/S0168-8278(00)80360-8.CrossRefPubMed
34.
Marceau N, Loranger A, Gilbert S, Daigle N, Champetier S: Keratin-mediated resistance to stress and apoptosis in simple epithelial cells in relation to health and disease. Biochem Cell Biol. 2001, 79: 543-555. 10.1139/bcb-79-5-543.CrossRefPubMed
35.
Omary MB, Ku NO, Toivola DM: Keratins: guardians of the liver. Hepatology. 2002, 35: 251-257. 10.1053/jhep.2002.31165.CrossRefPubMed
36.
Ku NO, Omary MB: Expression, glycosylation, and phosphorylation of human keratins 8 and 18 in insect cells. Exp Cell Res. 1994, 211: 24-35. 10.1006/excr.1994.1054.CrossRefPubMed
37.
Ku NO, Azhar S, Omary MB: Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization: modulation by a keratin 1-like disease causing mutation. J Biol Chem. 2002, 277: 10775-10782. 10.1074/jbc.M107623200.CrossRefPubMed
38.
Liao J, Lowthert LA, Omary MB: Heat stress or rotavirus infection of human epithelial cells generates a distinct hyperphosphorylated form of keratin 8. Exp Cell Res. 1995, 219: 348-357. 10.1006/excr.1995.1238.CrossRefPubMed
39.
Ku NO, Liao J, Chou CF, Omary MB: Implications of intermediate filament protein phosphorylation. Cancer Metastasis Rev. 1996, 15: 429-444.CrossRefPubMed
40.
Ku NO, Michie SA, Soetikno RM, Resurreccion EZ, Broome RL, Omary MB: Mutation of a major keratin phosphorylation site predisposes to hepatotoxic injury in transgenic mice. J Cell Biol. 1998, 143: 2023-2032. 10.1083/jcb.143.7.2023.PubMedCentralCrossRefPubMed
41.
Knasmuller S, Parzefall W, Helma C, Kassie F, Ecker S, Schulte-Hermann R: Toxic effects of griseofulvin: disease models, mechanisms, and risk assessment. Crit Rev Toxicol. 1997, 27: 495-537.CrossRefPubMed
42.
Stege GJ, Li L, Kampinga HH, Konings AW, Li GC: Importance of the ATP-binding domain and nucleolar localization domain of HSP72 in the protection of nuclear proteins against heat-induced aggregation. Exp Cell Res. 1994, 214: 279-284. 10.1006/excr.1994.1259.CrossRefPubMed
43.
Welch WJ, Feramisco JR: Nuclear and nucleolar localization of the 72,000-dalton heat shock protein in heat-shocked mammalian cells. J Biol Chem. 1984, 259: 4501-4513.PubMed
44.
Kawahara H, Cadrin M, French SW: Ethanol-induced phosphorylation of cytokeratin in cultured hepatocytes. Life Sci. 1990, 47: 859-863. 10.1016/0024-3205(90)90598-L.CrossRefPubMed
45.
Cadrin M, Anderson NM, Aasheim LH, Kawahara H, Franks DJ, French SW: Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice. Lab Invest. 1995, 72: 453-460.PubMed
46.
Ku NO, Liao J, Omary MB: Phosphorylation of human keratin 18 serine 33 regulates binding to 14-3-3 proteins. Embo J. 1998, 17: 1892-1906. 10.1093/emboj/17.7.1892.PubMedCentralCrossRefPubMed
47.
Ku NO, Michie S, Resurreccion EZ, Broome RL, Omary MB: Keratin binding to 14-3-3 proteins modulates keratin filaments and hepatocyte mitotic progression. Proc Natl Acad Sci U S A. 2002, 99: 4373-4378. 10.1073/pnas.072624299.PubMedCentralCrossRefPubMed
48.
Ku NO, Omary MB: Phosphorylation of human keratin 8 in vivo at conserved head domain serine 23 and at epidermal growth factor-stimulated tail domain serine 431. J Biol Chem. 1997, 272: 7556-7564. 10.1074/jbc.272.52.33197.CrossRefPubMed
49.
Stumptner C, Omary MB, Fickert P, Denk H, Zatloukal K: Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model. Am J Pathol. 2000, 156: 77-90.PubMedCentralCrossRefPubMed
50.
Liao J, Lowthert LA, Ghori N, Omary MB: The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem. 1995, 270: 915-922. 10.1074/jbc.270.2.915.CrossRefPubMed
51.
52.
Gabai VL, Meriin AB, Mosser DD, Caron AW, Rits S, Shifrin VI, Sherman MY: Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance. J Biol Chem. 1997, 272: 18033-18037. 10.1074/jbc.272.29.18033.CrossRefPubMed
53.
Bardag-Gorce F, van Leeuwen FW, Nguyen V, French BA, Li J, Riley N, McPhaul LW, Lue YH, French SW: The role of the ubiquitin-proteasome pathway in the formation of mallory bodies. Exp Mol Pathol. 2002, 73: 75-83. 10.1006/exmp.2002.2451.CrossRefPubMed
54.
Stumptner C, Fuchsbichler A, Lehner M, Zatloukal K, Denk H: Sequence of events in the assembly of Mallory body components in mouse liver: clues to the pathogenesis and significance of Mallory body formation. J Hepatol. 2001, 34: 665-675. 10.1016/S0168-8278(00)00099-4.CrossRefPubMed
55.
He T, Stepulak A, Holmstrom TH, Omary MB, Eriksson JE: The intermediate filament protein keratin 8 is a novel cytoplasmic substrate for c-Jun N-terminal kinase. J Biol Chem. 2002, 277: 10767-10774. 10.1074/jbc.M111436200.CrossRefPubMed
56.
Boller K, Kemler R, Baribault H, Doetschman T: Differential distribution of cytokeratins after microinjection of anti-cytokeratin monoclonal antibodies. Eur J Cell Biol. 1987, 43: 459-468.PubMed
57.
Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970, 227: 680-685.CrossRefPubMed
58.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Phenol folin reagent. J Biol Chem. 1951, 193: 265-275.PubMed
Metadata
Title
Heat shock protein 70 expression, keratin phosphorylation and Mallory body formation in hepatocytes from griseofulvin-intoxicated mice
Authors
Michel Fausther
Louis Villeneuve
Monique Cadrin
Publication date
01-01-2004
Publisher
BioMed Central
Published in
Comparative Hepatology / Issue 1/2004
Electronic ISSN: 1476-5926
DOI
https://doi.org/10.1186/1476-5926-3-5

Other articles of this Issue 1/2004

Comparative Hepatology 1/2004 Go to the issue

Research

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Research

The aryl hydrocarbon receptor-mediated disruption of vitellogenin synthesis in the fish liver: Cross-talk between AHR- and ERα-signalling pathways

Research

Liver sinusoidal endothelial cell modulation upon resection and shear stress in vitro

Research

Sodium nitroprusside and peroxynitrite effect on hepatic DNases: an in vitro and in vivostudy

Research

Intra-individual fasting versuspostprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

Editorial

Comparative Hepatology: A journal for all hepatologists with immediate Open Access to quality peer-reviewed research
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits